AMRX insider plans sale of 50,000 shares

AMRX filed a notice of proposed sale of up to 50,000 shares of common stock, to be sold through Merrill Lynch at 157 Church St., New Haven, CT, with a notation of NASDAQ as the trading market.

Rhea-AI Filing Summary

AMRX filed a notice of proposed sale of up to 50,000 shares of common stock, to be sold through Merrill Lynch at 157 Church St., New Haven, CT, with a notation of NASDAQ as the trading market. The filing also lists prior transactions over the past three months related to equity compensation.

Key Figures

Planned sale amount: 50,000 shares of common stock Recent equity-compensation shares 05/05/2021: 15,289 shares Recent equity-compensation shares 05/10/2024: 34,711 shares +1 more

4 metrics

Planned sale amount 50,000 shares of common stock Maximum shares listed in the Securities To Be Sold section

Recent equity-compensation shares 05/05/2021 15,289 shares Equity compensation common stock in past transactions section

Recent equity-compensation shares 05/10/2024 34,711 shares Equity compensation common stock in past transactions section

Trading market NASDAQ Listed as the market for the common stock to be sold

Key Terms

Securities To Be Sold, Securities Sold During The Past 3 Months, equity compensation

3 terms

Securities To Be Sold regulatory

"144: Securities To Be Sold COMMON STOCK | 05/05/2021"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months 144: Remarks"

equity compensation financial

"COMMON STOCK | 05/05/2021 | EQUITY COMPENSATION | ISSUER"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AMRX Form 144 filing report?

The filing reports a proposed sale of 50,000 shares of AMRX common stock through Merrill Lynch, with the shares listed for trading on NASDAQ, and includes a summary of recent equity-compensation-related transactions.

How many AMRX shares are planned to be sold under this Form 144?

The filer indicates an intention to sell up to 50,000 shares of AMRX common stock. This represents the maximum amount covered by this particular Form 144 notice of proposed sale.

Which broker is named in the AMRX Form 144 filing?

The filing identifies Merrill Lynch at 157 Church St., Floor 26, New Haven, CT 06510 as the broker handling the proposed sale of AMRX common stock.

What recent AMRX equity compensation transactions are disclosed?

The filing notes equity compensation-related common stock activity on 05/05/2021 and 05/10/2024, including amounts of 15,289 and 34,711 shares in the section covering securities sold during the past three months.

On which market are the AMRX shares in this Form 144 traded?

The common stock covered by this Form 144 is identified as trading on NASDAQ. This designation applies to the 50,000 shares of common stock listed in the proposed sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2026 - 04:15 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001781149
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AMNEAL PHARMACEUTICALS, INC
SEC File Number	001-38485
Address of Issuer	400 CROSSING BLVD, 3RD FLOOR BRIDGEWATER NEW JERSEY 08807
Phone	9089473120
Name of Person for Whose Account the Securities are To Be Sold	JOHN KIELY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON STOCK	MERRILL LYNCH 157 CHURCH ST, FL 26 NEW HAVEN CT 06510	50000	879714	319353919	08/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON STOCK	05/05/2021	EQUITY COMPENSATION	ISSUER			15289	05/05/2021	EQUITY COMPENSATION
COMMON STOCK	05/10/2024	EQUITY COMPENSATION	ISSUER			34711	05/10/2024	EQUITY COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	JOHN KIELY
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)